Canada’s Drug Agency: guidance document on use of AI methods & summary of precision medicine initiatives

In July 2026, Canada’s Drug Agency (CDA) published Use of Artificial Intelligence Methods to Generate Real-World Evidence Submitted to Canada’s Drug Agency for HTA. This guidance document describes principles for use of AI methods to extract variables from unstructured data to generate real-world evidence for health technology assessment submissions.... By: Smart & Biggar